Pharma MSMEs Grapple with Inverted Duty Structure as Pharmexcil Seeks Policy Reform
The Impact of Inverted Duty on Pharma MSMEs The Pharmaceutical Export Promotion Council of India (Pharmexcil) has formally initiated a sector-wide consultation process to address the mounting financial strain on Micro, Small, and Medium Enterprises (MSMEs) caused by an inverted duty structure. As of late 2023 and early 2024, small-scale drug manufacturers have reported that…